In the February 2, 2009 issue of the Archives of General Psychiatry, Eric Elbogen, Ph.D., assistant professor of forensic psychiatry at the University of North Carolina Chapel Hill…
NEW YORK (Reuters Health) – Long-term strenuous activity may cut the risk of breast cancer in women, but may have a harmful effect on cognition, according to study…
Margaret McHugh, MD, MPH, Associate Professor at NYU School of Medicine, Director of Adolescent Clinic and Child Protection Team, Bellevue Hospital, discusses child abuse, neglect and child safety,…
NEW YORK (Reuters Health) – New research suggests that treatment with methylphenidate and other stimulants may help prevent the development of comorbid psychiatric disorders, as well as improve…
NEW YORK (Reuters Health) – New research suggests that for some patients with cancer, especially brain tumors and small-cell-lung cancer, the first manifestation is a psychiatric symptom. The…
NEW YORK (Reuters Health) – Dementia and use of dopaminergic agents, principally pergolide, are risk factors for psychotic symptoms in patients with Parkinson’s disease, according to a report…
NEW YORK (Reuters Health) – Children and adolescents who use stimulant medications, primarily methylphenidate, are at increased risk for sudden death, according to a report in The American…
Stuart Gitlow, MD, MPH, MBA, Executive Director, Annenberg Physician Training Program in Addictive Disease, discusses alcoholism and argues that it is in fact a disease rather than a…
NEW YORK (Reuters Health) – The genotype for the serotonin transporter (5-HTTLPR) is not a risk factor for depression, nor does it interact with stressful life events to…
NEW YORK (Reuters Health) – Changes in the diagnosis and treatment of depression occurred soon after the US Food and Drug Administration warned in 2003 of a suicidality…